KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Palvella Therapeutics (PVLA) Return on Equity (2016 - 2026)

Palvella Therapeutics has reported Return on Equity over the past 9 years, most recently at 0.01% for Q2 2022.

  • Quarterly Return on Equity changed 0.0% to 0.01% in Q2 2022 from the year-ago period, while the trailing twelve-month figure was 0.01% through Jun 2022, changed 0.0% year-over-year, with the annual reading at 0.01% for FY2021, 0.0% changed from the prior year.
  • Return on Equity was 0.01% for Q2 2022 at Palvella Therapeutics, up from 0.01% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q3 2018 and troughed at 0.02% in Q3 2019.
  • The 5-year median for Return on Equity is 0.01% (2020), against an average of 0.01%.
  • Year-over-year, Return on Equity grew 4bps in 2018 and then decreased -2bps in 2019.
  • A 5-year view of Return on Equity shows it stood at 0.01% in 2018, then decreased by -19bps to 0.01% in 2019, then decreased by -26bps to 0.01% in 2020, then dropped by -11bps to 0.01% in 2021, then dropped by -2bps to 0.01% in 2022.
  • Per Business Quant, the three most recent readings for PVLA's Return on Equity are 0.01% (Q2 2022), 0.01% (Q1 2022), and 0.01% (Q4 2021).